
While preliminary tests found low levels of the nitrosamine impurity N-nitrosodimethylamine (NDMA) in some ranitidine products, the FDA said this does not mean patients taking the drugs should stop using them now.
from WebMD Health https://ift.tt/2ZYYPbg
via IFTTT
Comments
Post a Comment